Skip to main content
18 November 2026

Medtronic to acquire Contego Medical

Medtronic the global leader in healthcare technology ann,ounced its intent to acquire Contego Medical, a privately held medical device company focused on innovative solutions for carotid artery disease and peripheral thrombectomy.

The acquisition will build on the company's successful, exclusive U.S. distribution agreement with Contego, first announced in January 2025, and advances the Medtronic strategy of pursuing targeted investments that strengthen the company's core franchises. The deal specifically expands the Medtronic portfolio of differentiated carotid technologies, broadening patient access to innovative therapies for carotid artery and peripheral vascular disease.

"With this acquisition, Medtronic is taking another important step to strengthen our leadership in the treatment of carotid artery disease," said David Moeller, senior vice president and president of Medtronic Peripheral Vascular Health, which is part of the company's Cardiovascular portfolio. "By pairing Medtronic's deep clinical expertise in peripheral and neurovascular technologies with Contego's next-generation treatments backed by strong and consistent clinical data,† we intend to become an undisputed leader in carotid revascularization."

Carotid artery disease occurs when the carotid arteries, the major blood vessels supplying the brain, become narrowed or blocked. Plaque can then rupture or embolize and lead to a stroke, accounting for about 20% of ischemic strokes. While carotid revascularization is intended to reduce stroke risk, embolic debris released during treatment can contribute to procedural stroke risk.2-5 Contego Medical, founded by Ravish Sachar, MD, and Jay Yadav, MD, developed technology designed to address this challenge through integrated embolic protection.

"Contego was founded to address unmet needs in clinical practice by developing technologies designed to improve outcomes while simultaneously simplifying procedures. Deepening our partnership with Medtronic is an exciting next chapter," said Ravish Sachar, MD, Founder and Chief Executive Officer of Contego Medical. "We're proud of our team and grateful to the physicians, study sites, employees, and investors who helped bring these technologies to patients."

slot gacor